ETF Holdings Breakdown of JAZZ

Stock Name	Jazz Pharmaceuticals PLC
Ticker	JAZZ(USD) NASDAQ
TYPE	Common Stock
Country	USA
ISIN	IE00B4Q5ZN47

JAZZ institutional holdings

The adjusted close for JAZZ on 2025-12-17 was 164.91

The following institutional investment holdings of JAZZ have been identified

Date ETF ISIN/Name Num Shares Book value Derived Price per Share Comment
2025-12-17 IE000T9EOCL3 (iShares MSCI World Small Cap ESG Enhanced UCITS ETF USD (Acc)) 1,362 USD 224,614 -2.9% 164.91

2025-12-17 IE00B3VWM098 (iShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc) 28,919 USD 4,769,177 164.92 Incorrect share price reported. Should be 164.91 not 164.92. May be due to incorrect reporting of currency . Could be EUR or USD instead

2025-12-17 IE00BDZVHG35 (iShares Nasdaq US Biotechnology UCITS ETF USD (Dist)) 44,948 -1.1% USD 7,412,599 -4.1% 164.91

2025-12-17 IE00BF4RFH31 (iShares MSCI World Small Cap UCITS ETF USD (Acc)) 40,541 USD 6,685,819 -2.9% 164.91

2025-12-17 IE00BYXG2H39 (iShares Nasdaq US Biotechnology UCITS ETF USD (Acc)) 44,948 -1.1% USD 7,412,599 -4.1% 164.91

2025-12-16 IE0002EKOXU6 (iShares Russell 1000 Value UCITS ETF) 518 USD 87,920 0.1% 169.73 Incorrect share price reported. Should be 164.91 not 169.73. May be due to incorrect reporting of currency . Could be EUR or USD instead

Total = 161,236 USD 26,592,728
Book value of shares is calculated on the adjusted close price of each day (row).

Date	ETF ISIN/Name	Num Shares	Book value	Derived Price per Share
2025-12-17	IE000T9EOCL3 (iShares MSCI World Small Cap ESG Enhanced UCITS ETF USD (Acc))	1,362	USD 224,614 -2.9%	164.91
2025-12-17	IE00B3VWM098 (iShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc)	28,919	USD 4,769,177	164.92 Incorrect share price reported. Should be 164.91 not 164.92. May be due to incorrect reporting of currency . Could be EUR or USD instead
2025-12-17	IE00BDZVHG35 (iShares Nasdaq US Biotechnology UCITS ETF USD (Dist))	44,948 -1.1%	USD 7,412,599 -4.1%	164.91
2025-12-17	IE00BF4RFH31 (iShares MSCI World Small Cap UCITS ETF USD (Acc))	40,541	USD 6,685,819 -2.9%	164.91
2025-12-17	IE00BYXG2H39 (iShares Nasdaq US Biotechnology UCITS ETF USD (Acc))	44,948 -1.1%	USD 7,412,599 -4.1%	164.91
2025-12-16	IE0002EKOXU6 (iShares Russell 1000 Value UCITS ETF)	518	USD 87,920 0.1%	169.73 Incorrect share price reported. Should be 164.91 not 169.73. May be due to incorrect reporting of currency . Could be EUR or USD instead
Total =	161,236	USD 26,592,728

News associated with JAZZ

Jazz Pharmaceuticals (NASDAQ:JAZZ) Price Target Raised to $185.00: Jazz Pharmaceuticals (NASDAQ:JAZZ – Free Report) had its price target hoisted by The Goldman Sachs Group from $162.00 to $185.00 in a research report report published on Friday morning,Benzinga reports. The Goldman Sachs Group currently has a buy rating on the specialty pharmaceutical company’s stock. A number of other research analysts also recently commented on […] - 2025-09-01 02:59:05
Brokerages Set Jazz Pharmaceuticals PLC (NASDAQ:JAZZ) Target Price at $181.43: Shares of Jazz Pharmaceuticals PLC (NASDAQ:JAZZ – Get Free Report) have been given an average recommendation of “Moderate Buy” by the fourteen brokerages that are covering the firm, Marketbeat reports. One analyst has rated the stock with a hold recommendation and thirteen have assigned a buy recommendation to the company. The average 1 year target […] - 2025-08-19 03:06:58
Swiss National Bank Trims Stock Position in Jazz Pharmaceuticals PLC (NASDAQ:JAZZ): Swiss National Bank decreased its position in Jazz Pharmaceuticals PLC (NASDAQ:JAZZ – Free Report) by 3.6% in the first quarter, Holdings Channel reports. The firm owned 111,300 shares of the specialty pharmaceutical company’s stock after selling 4,100 shares during the period. Swiss National Bank’s holdings in Jazz Pharmaceuticals were worth $13,818,000 at the end of […] - 2025-08-15 05:24:55
Vanguard Group Inc. Has $747.06 Million Stake in Jazz Pharmaceuticals PLC (NASDAQ:JAZZ): Vanguard Group Inc. trimmed its holdings in Jazz Pharmaceuticals PLC (NASDAQ:JAZZ – Free Report) by 0.3% in the first quarter, Holdings Channel reports. The institutional investor owned 6,017,403 shares of the specialty pharmaceutical company’s stock after selling 18,780 shares during the period. Vanguard Group Inc. owned approximately 0.10% of Jazz Pharmaceuticals worth $747,061,000 at the […] - 2025-08-13 06:14:46
Jazz Pharmaceuticals PLC (NASDAQ:JAZZ) Shares Purchased by PNC Financial Services Group Inc.: PNC Financial Services Group Inc. lifted its position in Jazz Pharmaceuticals PLC (NASDAQ:JAZZ – Free Report) by 8.0% in the 1st quarter, HoldingsChannel.com reports. The firm owned 5,128 shares of the specialty pharmaceutical company’s stock after acquiring an additional 379 shares during the quarter. PNC Financial Services Group Inc.’s holdings in Jazz Pharmaceuticals were worth […] - 2025-08-13 04:38:53
Cetera Investment Advisers Purchases 444 Shares of Jazz Pharmaceuticals PLC (NASDAQ:JAZZ): Cetera Investment Advisers increased its position in Jazz Pharmaceuticals PLC (NASDAQ:JAZZ – Free Report) by 4.4% during the first quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 10,536 shares of the specialty pharmaceutical company’s stock after purchasing an additional 444 shares during the quarter. Cetera Investment […] - 2025-08-11 04:18:46
Jazz Pharmaceuticals PLC (NASDAQ:JAZZ) Shares Sold by Allianz Asset Management GmbH: Allianz Asset Management GmbH lessened its stake in Jazz Pharmaceuticals PLC (NASDAQ:JAZZ – Free Report) by 24.9% during the first quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 58,745 shares of the specialty pharmaceutical company’s stock after selling 19,447 shares during the quarter. […] - 2025-07-28 04:36:57
Y Intercept Hong Kong Ltd Grows Stake in Jazz Pharmaceuticals PLC (NASDAQ:JAZZ): Y Intercept Hong Kong Ltd increased its holdings in shares of Jazz Pharmaceuticals PLC (NASDAQ:JAZZ – Free Report) by 269.5% in the 1st quarter, HoldingsChannel.com reports. The firm owned 9,721 shares of the specialty pharmaceutical company’s stock after acquiring an additional 7,090 shares during the period. Y Intercept Hong Kong Ltd’s holdings in Jazz Pharmaceuticals […] - 2025-07-25 06:11:00
Jazz Pharmaceuticals PLC (NASDAQ:JAZZ) Receives $181.71 Consensus Price Target from Analysts: Shares of Jazz Pharmaceuticals PLC (NASDAQ:JAZZ – Get Free Report) have been assigned an average recommendation of “Moderate Buy” from the fourteen ratings firms that are presently covering the stock, MarketBeat Ratings reports. One analyst has rated the stock with a hold rating and thirteen have assigned a buy rating to the company. The average […] - 2025-07-25 04:35:13
Jazz Pharmaceuticals PLC (NASDAQ:JAZZ) Shares Acquired by Xponance Inc.: Xponance Inc. raised its position in shares of Jazz Pharmaceuticals PLC (NASDAQ:JAZZ – Free Report) by 8.2% in the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 8,594 shares of the specialty pharmaceutical company’s stock after acquiring an additional 648 shares during the […] - 2025-07-17 07:42:48
Jazz Pharmaceuticals (NASDAQ:JAZZ) Now Covered by Deutsche Bank Aktiengesellschaft: Analysts at Deutsche Bank Aktiengesellschaft initiated coverage on shares of Jazz Pharmaceuticals (NASDAQ:JAZZ – Get Free Report) in a research report issued to clients and investors on Tuesday, Marketbeat.com reports. The brokerage set a “buy” rating and a $152.00 price target on the specialty pharmaceutical company’s stock. Deutsche Bank Aktiengesellschaft’s price objective indicates a potential […] - 2025-07-17 06:19:01
Cerity Partners LLC Acquires 4,744 Shares of Jazz Pharmaceuticals PLC (NASDAQ:JAZZ): Cerity Partners LLC raised its holdings in Jazz Pharmaceuticals PLC (NASDAQ:JAZZ – Free Report) by 14.3% during the 1st quarter, Holdings Channel.com reports. The institutional investor owned 37,949 shares of the specialty pharmaceutical company’s stock after acquiring an additional 4,744 shares during the quarter. Cerity Partners LLC’s holdings in Jazz Pharmaceuticals were worth $4,711,000 at […] - 2025-07-17 05:00:57
State of Michigan Retirement System Has $1.80 Million Stock Position in Jazz Pharmaceuticals PLC (NASDAQ:JAZZ): State of Michigan Retirement System increased its stake in Jazz Pharmaceuticals PLC (NASDAQ:JAZZ – Free Report) by 1.4% in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 14,504 shares of the specialty pharmaceutical company’s stock after buying an additional 200 shares […] - 2025-07-15 06:28:18
Jazz Pharmaceuticals PLC (NASDAQ:JAZZ) Shares Acquired by OneDigital Investment Advisors LLC: OneDigital Investment Advisors LLC grew its stake in Jazz Pharmaceuticals PLC (NASDAQ:JAZZ – Free Report) by 10.6% in the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 3,932 shares of the specialty pharmaceutical company’s stock after buying an additional 377 shares during […] - 2025-07-11 07:30:53
Jazz Pharmaceuticals PLC (NASDAQ:JAZZ) Shares Sold by Teacher Retirement System of Texas: Teacher Retirement System of Texas reduced its holdings in Jazz Pharmaceuticals PLC (NASDAQ:JAZZ – Free Report) by 10.9% in the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 15,470 shares of the specialty pharmaceutical company’s stock after selling 1,902 shares during the quarter. Teacher Retirement System […] - 2025-07-11 05:14:57
Vontobel Holding Ltd. Lowers Holdings in Jazz Pharmaceuticals PLC (NASDAQ:JAZZ): Vontobel Holding Ltd. trimmed its holdings in Jazz Pharmaceuticals PLC (NASDAQ:JAZZ – Free Report) by 15.5% in the 1st quarter, according to its most recent disclosure with the SEC. The firm owned 3,577 shares of the specialty pharmaceutical company’s stock after selling 656 shares during the period. Vontobel Holding Ltd.’s holdings in Jazz Pharmaceuticals were […] - 2025-07-08 05:30:53
Allspring Global Investments Holdings LLC Sells 489 Shares of Jazz Pharmaceuticals PLC (NASDAQ:JAZZ): Allspring Global Investments Holdings LLC trimmed its holdings in shares of Jazz Pharmaceuticals PLC (NASDAQ:JAZZ – Free Report) by 3.1% during the first quarter, Holdings Channel.com reports. The fund owned 15,129 shares of the specialty pharmaceutical company’s stock after selling 489 shares during the quarter. Allspring Global Investments Holdings LLC’s holdings in Jazz Pharmaceuticals were […] - 2025-07-08 04:32:49
Envestnet Portfolio Solutions Inc. Buys 1,223 Shares of Jazz Pharmaceuticals PLC (NASDAQ:JAZZ): Envestnet Portfolio Solutions Inc. raised its holdings in Jazz Pharmaceuticals PLC (NASDAQ:JAZZ – Free Report) by 38.9% during the 1st quarter, HoldingsChannel.com reports. The fund owned 4,369 shares of the specialty pharmaceutical company’s stock after buying an additional 1,223 shares during the period. Envestnet Portfolio Solutions Inc.’s holdings in Jazz Pharmaceuticals were worth $542,000 at […] - 2025-06-27 05:08:51
15,296 Shares in Jazz Pharmaceuticals plc (NASDAQ:JAZZ) Acquired by Ritholtz Wealth Management: Ritholtz Wealth Management bought a new position in shares of Jazz Pharmaceuticals plc (NASDAQ:JAZZ – Free Report) in the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor bought 15,296 shares of the specialty pharmaceutical company’s stock, valued at approximately $1,899,000. A number of other […] - 2025-06-17 07:00:52
Yousif Capital Management LLC Decreases Stock Position in Jazz Pharmaceuticals plc (NASDAQ:JAZZ): Yousif Capital Management LLC cut its holdings in Jazz Pharmaceuticals plc (NASDAQ:JAZZ – Free Report) by 2.6% in the first quarter, HoldingsChannel reports. The institutional investor owned 12,644 shares of the specialty pharmaceutical company’s stock after selling 342 shares during the quarter. Yousif Capital Management LLC’s holdings in Jazz Pharmaceuticals were worth $1,570,000 as of […] - 2025-06-17 05:08:52
Jazz Pharmaceuticals plc (NASDAQ:JAZZ) Shares Purchased by Wealth Enhancement Advisory Services LLC: Wealth Enhancement Advisory Services LLC raised its stake in Jazz Pharmaceuticals plc (NASDAQ:JAZZ – Free Report) by 22.1% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 4,102 shares of the specialty pharmaceutical company’s stock after purchasing an additional 743 shares during […] - 2025-06-13 04:34:51
2,265 Shares in Jazz Pharmaceuticals plc (NASDAQ:JAZZ) Purchased by Merit Financial Group LLC: Merit Financial Group LLC bought a new position in Jazz Pharmaceuticals plc (NASDAQ:JAZZ – Free Report) in the 1st quarter, Holdings Channel.com reports. The institutional investor bought 2,265 shares of the specialty pharmaceutical company’s stock, valued at approximately $281,000. Several other large investors have also recently modified their holdings of JAZZ. IFP Advisors Inc bought […] - 2025-06-12 05:32:55
Wedmont Private Capital Sells 903 Shares of Jazz Pharmaceuticals plc (NASDAQ:JAZZ): Wedmont Private Capital trimmed its position in Jazz Pharmaceuticals plc (NASDAQ:JAZZ – Free Report) by 13.3% during the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 5,912 shares of the specialty pharmaceutical company’s stock after selling 903 shares during the period. […] - 2025-06-10 05:33:02
Focus Partners Wealth Invests $551,000 in Jazz Pharmaceuticals plc (NASDAQ:JAZZ): Focus Partners Wealth bought a new position in shares of Jazz Pharmaceuticals plc (NASDAQ:JAZZ – Free Report) in the fourth quarter, HoldingsChannel reports. The institutional investor bought 4,469 shares of the specialty pharmaceutical company’s stock, valued at approximately $551,000. A number of other hedge funds also recently modified their holdings of the stock. Bessemer Group […] - 2025-05-20 07:12:52
Hsbc Holdings PLC Acquires 605 Shares of Jazz Pharmaceuticals plc (NASDAQ:JAZZ): Hsbc Holdings PLC boosted its holdings in shares of Jazz Pharmaceuticals plc (NASDAQ:JAZZ – Free Report) by 26.7% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 2,871 shares of the specialty pharmaceutical company’s stock after buying an additional 605 […] - 2025-05-09 05:34:54
Jazz Pharmaceuticals plc (NASDAQ:JAZZ) Stock Position Raised by Townsquare Capital LLC: Townsquare Capital LLC lifted its position in Jazz Pharmaceuticals plc (NASDAQ:JAZZ – Free Report) by 79.5% in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 3,540 shares of the specialty pharmaceutical company’s stock after buying an additional 1,568 shares during the quarter. Townsquare […] - 2025-04-21 05:00:54
Jazz Pharmaceuticals plc (NASDAQ:JAZZ) Shares Sold by Bank of Montreal Can: Bank of Montreal Can reduced its position in Jazz Pharmaceuticals plc (NASDAQ:JAZZ – Free Report) by 11.6% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 17,194 shares of the specialty pharmaceutical company’s stock after selling 2,253 shares during the period. Bank of […] - 2025-04-17 05:42:52
Jazz Pharmaceuticals plc (NASDAQ:JAZZ) Shares Sold by Wells Fargo & Company MN: Wells Fargo & Company MN lessened its holdings in shares of Jazz Pharmaceuticals plc (NASDAQ:JAZZ – Free Report) by 17.1% during the fourth quarter, HoldingsChannel reports. The fund owned 96,952 shares of the specialty pharmaceutical company’s stock after selling 20,063 shares during the period. Wells Fargo & Company MN’s holdings in Jazz Pharmaceuticals were worth […] - 2025-04-16 05:27:14
Fmr LLC Has $91.42 Million Stock Position in Jazz Pharmaceuticals plc (NASDAQ:JAZZ): Fmr LLC cut its position in Jazz Pharmaceuticals plc (NASDAQ:JAZZ – Free Report) by 11.2% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 742,305 shares of the specialty pharmaceutical company’s stock after selling 93,576 shares during the period. Fmr LLC […] - 2025-04-16 04:34:53
Jazz Pharmaceuticals plc (NASDAQ:JAZZ) Given Consensus Recommendation of “Moderate Buy” by Brokerages: Jazz Pharmaceuticals plc (NASDAQ:JAZZ – Get Free Report) has been assigned a consensus recommendation of “Moderate Buy” from the fourteen ratings firms that are covering the firm, MarketBeat Ratings reports. One investment analyst has rated the stock with a hold rating and thirteen have given a buy rating to the company. The average twelve-month target […] - 2025-04-13 05:34:43

Back to Listing

Disclaimer

All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.